Research Finds Women Taking GLP-1 Weight-Loss Drugs Could Be More Likely To Get Hired.
Employer weight bias may give thinner individuals an advantage in hiring and career opportunities.
In 2026, landing a new job may depend on more than just a strong résumé or interview performance. A new study suggests that, for some women, using GLP-1 weight-loss medications such as Ozempic or Wegovy may also be linked to improved hiring outcomes.
According to research highlighted by Fast Company, women who used GLP-1 weight-loss medications were significantly more likely to secure employment than women who wanted the medications but had not taken them. The findings suggest a possible association between GLP-1 use and hiring outcomes, though they do not establish that the medications directly caused the difference.
The study, led by Harvard economics professor Rebecca Diamond, examined data from more than 10,000 adults gathered through a University of Southern California survey. Researchers compared women who started using GLP-1 weight-loss medications with those who were interested in the drugs but had not yet begun treatment.
The findings showed that unemployed women who took GLP-1 medications were 27% more likely to gain employment within 18 months than women who did not start the treatment. While the study identified a significant association, it does not establish that the medications directly caused the improved employment outcomes.
“The estimates show that GLP-1 weight loss changes outcomes on precisely the margins where visible body weight should affect first impressions,” Diamond wrote in the study.
The findings suggest that first impressions may play an important role in the hiring process for women seeking employment. However, among women who were already employed, starting GLP-1 medications was not associated with meaningful changes in earnings, hours worked, or career advancement.
“What does not change for women is equally informative,” Diamond noted. “The arrangements that do not respond are the ones already in place, where any first impression occurred long ago and where weight is one characteristic embedded in a much richer stock of information.”
Beyond employment, the study found that single women taking GLP-1 medications were 29% more likely to get married or begin living with a partner within 18 months. In contrast, women who were already in committed relationships experienced little to no change in their relationship status.
These findings are consistent with previous research highlighting the impact of weight bias in hiring. Earlier studies have shown that individuals with obesity are often viewed as less motivated or less productive, despite a lack of evidence to support those perceptions.
Diamond cautioned that the study has not yet undergone peer review and does not establish that employers are directly discriminating against applicants based on body weight. She noted that other factors—such as improvements in physical health or greater self-confidence following weight loss—may also contribute to better employment outcomes. However, according to Business Insider, the study found that these factors explained only part of the observed differences.
